Sunset Villa Care Center | |
1515 South Sunset Ave, Roswell, New Mexico 88203 | |
(575) 623-7097 | |
Name | Sunset Villa Care Center |
---|---|
Location | 1515 South Sunset Ave, Roswell, New Mexico |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 52 |
Occupancy Rate | 40% |
Medicare ID (CCN) | 325117 |
Legal Business Name | Thi Of New Mexico At Sunset Villa, Llc |
Ownership Type | For Profit - Limited Liability Company |
NPI Number | 1013004209 |
Organization Name | THI OF NEW MEXICO AT SUNSET VILLA, LLC |
Doing Business As | SUNSET VILLA CARE CENTER |
Address | 1515 S Sunset Ave, Roswell, NM 88203 |
Phone Number | 505-623-7097 |
News Archive
This is a great day in the fight against AIDS. The positive results of the iPrEx oral PrEP study are a major milestone in HIV prevention research and provide important information about how antiretroviral drugs might be used for prevention by HIV-negative people at high risk for HIV infection, said AVAC Executive Director Mitchell Warren.
In a breakthrough that may help fill a critical need in stem cell research and patient care, researchers at Mount Sinai School of Medicine have demonstrated that skin cells found in human amniotic fluid can be efficiently "reprogrammed" to pluripotency, where they have characteristics similar to human embryonic stem cells that can develop into almost any type of cell in the human body. The study is online now and will appear in print in the next issue of the journal Cellular Reprogramming, to be published next month.
Tod Preston, director of government relations at the U.S. Global Leadership Coalition, discusses four theories on what could happen with U.S. budget negotiations and the possible effects on foreign aid.
Mass producing human pluripotent stem cells (hPSCs), including embryonic stem cells and induced pluripotent stem cells, for regenerative medicine and drug discovery may have gotten much easier, thanks to a polymer-based 3D culture system developed by Japanese researchers.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has raised a total of $48.4 million from its Series B financing following receipt of the third tranche to advance the company's product development programs.
› Verified 4 days ago
NPI Number | 1598479420 |
Organization Name | SUNSET VILLA HEALTHCARE LLC |
Address | 1515 S Sunset Ave, Roswell, NM 88203 |
Phone Number | 575-623-7097 |
News Archive
This is a great day in the fight against AIDS. The positive results of the iPrEx oral PrEP study are a major milestone in HIV prevention research and provide important information about how antiretroviral drugs might be used for prevention by HIV-negative people at high risk for HIV infection, said AVAC Executive Director Mitchell Warren.
In a breakthrough that may help fill a critical need in stem cell research and patient care, researchers at Mount Sinai School of Medicine have demonstrated that skin cells found in human amniotic fluid can be efficiently "reprogrammed" to pluripotency, where they have characteristics similar to human embryonic stem cells that can develop into almost any type of cell in the human body. The study is online now and will appear in print in the next issue of the journal Cellular Reprogramming, to be published next month.
Tod Preston, director of government relations at the U.S. Global Leadership Coalition, discusses four theories on what could happen with U.S. budget negotiations and the possible effects on foreign aid.
Mass producing human pluripotent stem cells (hPSCs), including embryonic stem cells and induced pluripotent stem cells, for regenerative medicine and drug discovery may have gotten much easier, thanks to a polymer-based 3D culture system developed by Japanese researchers.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has raised a total of $48.4 million from its Series B financing following receipt of the third tranche to advance the company's product development programs.
› Verified 4 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
This is a great day in the fight against AIDS. The positive results of the iPrEx oral PrEP study are a major milestone in HIV prevention research and provide important information about how antiretroviral drugs might be used for prevention by HIV-negative people at high risk for HIV infection, said AVAC Executive Director Mitchell Warren.
In a breakthrough that may help fill a critical need in stem cell research and patient care, researchers at Mount Sinai School of Medicine have demonstrated that skin cells found in human amniotic fluid can be efficiently "reprogrammed" to pluripotency, where they have characteristics similar to human embryonic stem cells that can develop into almost any type of cell in the human body. The study is online now and will appear in print in the next issue of the journal Cellular Reprogramming, to be published next month.
Tod Preston, director of government relations at the U.S. Global Leadership Coalition, discusses four theories on what could happen with U.S. budget negotiations and the possible effects on foreign aid.
Mass producing human pluripotent stem cells (hPSCs), including embryonic stem cells and induced pluripotent stem cells, for regenerative medicine and drug discovery may have gotten much easier, thanks to a polymer-based 3D culture system developed by Japanese researchers.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has raised a total of $48.4 million from its Series B financing following receipt of the third tranche to advance the company's product development programs.
› Verified 4 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 5 |
Total Amount of Fines in Dollars | $24457 |
Number of Payment Denials | 1 |
Total Number of Penalties | 6 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 10.42 | 14.46 |
Percentage of long-stay residents who lose too much weight | 0 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 58.54 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.05 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 14.42 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.75 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 95.41 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 17.53 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 93.01 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 16.58 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.4 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.49 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 87.14 | 95.98 |
Percentage of short-stay residents who made improvements in function | 68.87 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 81.25 | 82.93 |
News Archive
This is a great day in the fight against AIDS. The positive results of the iPrEx oral PrEP study are a major milestone in HIV prevention research and provide important information about how antiretroviral drugs might be used for prevention by HIV-negative people at high risk for HIV infection, said AVAC Executive Director Mitchell Warren.
In a breakthrough that may help fill a critical need in stem cell research and patient care, researchers at Mount Sinai School of Medicine have demonstrated that skin cells found in human amniotic fluid can be efficiently "reprogrammed" to pluripotency, where they have characteristics similar to human embryonic stem cells that can develop into almost any type of cell in the human body. The study is online now and will appear in print in the next issue of the journal Cellular Reprogramming, to be published next month.
Tod Preston, director of government relations at the U.S. Global Leadership Coalition, discusses four theories on what could happen with U.S. budget negotiations and the possible effects on foreign aid.
Mass producing human pluripotent stem cells (hPSCs), including embryonic stem cells and induced pluripotent stem cells, for regenerative medicine and drug discovery may have gotten much easier, thanks to a polymer-based 3D culture system developed by Japanese researchers.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has raised a total of $48.4 million from its Series B financing following receipt of the third tranche to advance the company's product development programs.
› Verified 4 days ago
Mission Arch Center Location: 3200 Mission Arch Drive, Roswell, New Mexico 88201 Phone: (575) 624-2583 | |
Casa Maria Healthcare Center And Pecos Valley Reha Location: 1601 South Main Street, Roswell, New Mexico 88203 Phone: (575) 623-6008 | |
Sunset Villa Care Center Location: 1515 South Sunset Ave, Roswell, New Mexico 88203 Phone: (575) 623-7097 |